000 | 01320cam a2200289 4500500 | ||
---|---|---|---|
005 | 20250112040114.0 | ||
041 | _afre | ||
042 | _adc | ||
100 | 1 | 0 |
_aLamarque, Catherine _eauthor |
700 | 1 | 0 |
_a Lamarque, Dominique _eauthor |
245 | 0 | 0 | _aAn update on the prevention of bleeding ulcers in 2023 |
260 | _c2023. | ||
500 | _a49 | ||
520 | _aPeptic ulcer disease is a known complication in patients in intensive care units or on anticoagulants who are being given non-steroidal anti-inflammatory drugs. Screening and treatment for Helicobacter pylori should be offered to patients starting NSAID therapy. Proton pump inhibitors should be given to patients at high risk of developing a bleeding ulcer and dying from this complication. | ||
690 | _arisk-benefit | ||
690 | _anon-steroidal anti-inflammatory drugs | ||
690 | _aproton pump inhibitor | ||
690 | _apeptic ulcer | ||
690 | _aHelicobacter pylori | ||
690 | _arisk-benefit | ||
690 | _anon-steroidal anti-inflammatory drugs | ||
690 | _apulcer | ||
690 | _aproton pump inhibitor | ||
690 | _aHelicobacter pylori | ||
786 | 0 | _nHépato-Gastro & Oncologie Digestive | 30 | 3 | 2023-03-02 | p. 335-342 | 2115-3310 | |
856 | 4 | 1 | _uhttps://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-3-page-335?lang=en |
999 |
_c175211 _d175211 |